Chunghwa Chemical Synthesis & Biotech Co Ltd Sustainability Reports
Chunghwa Chemical Synthesis & Biotech Co., Ltd. researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) internationally. Its product line includes specialized synthetic and biotechnology-derived APIs such as immunosuppressants, antifungals, and cardiovascular agents.
Sector: Manufacturing
Country: Taiwan
Exchange: Taiwan Stock Exchange
FIGI: BBG001T651W9
25 reports from 2013 to 2024
- Chunghwa Chemical Synthesis & Biotech Co Ltd 2024 Sustainability Report
- Chunghwa Chemical Synthesis & Biotech Co Ltd 2024 Sustainability Report
- Chunghwa Chemical Synthesis & Biotech Co Ltd 2023 Annual Report
- Chunghwa Chemical Synthesis & Biotech Co Ltd 2023 Sustainability Report
- Chunghwa Chemical Synthesis & Biotech Co Ltd 2022 Sustainability Report